59 Avsnitt

  1. Holy poop! Mental health and the gut (part 2 with Bloom Science)

    Publicerades: 2023-09-28
  2. Holy poop! Mental health and the gut (part 1 with Holobiome)

    Publicerades: 2023-09-14
  3. Ketamine for OCD: Carolyn Rodriguez (Stanford pt 3)

    Publicerades: 2023-08-24
  4. Are psychedelics effective under anesthesia?: Boris Heifets (Stanford pt 2)

    Publicerades: 2023-08-17
  5. The Startup Landscape for Expanding Consciousness

    Publicerades: 2023-08-09
  6. Stanford Psychedelic Overview: Robert Malenka (Stanford pt 1)

    Publicerades: 2023-07-20
  7. Live from Psychedelic Science 2023

    Publicerades: 2023-07-07
  8. What VCs Look for in Psychedelic Companies

    Publicerades: 2023-06-09
  9. Developing Non-Hallucinogenic Psychedelics: Bryan Roth

    Publicerades: 2023-05-15
  10. Behind the Scenes of PsyMed Ventures

    Publicerades: 2023-04-14
  11. The 2023 Psychedelic Industry Landscape with Psychedelic Alpha

    Publicerades: 2023-02-27
  12. The State of Psychedelics (Part 2): Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)

    Publicerades: 2023-01-18
  13. The quest to improve MDMA

    Publicerades: 2022-12-20
  14. Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment

    Publicerades: 2022-11-29
  15. Perspectives from Christian Angermayer, investor and founder in psychedelics

    Publicerades: 2022-10-27
  16. Soltara: an ethical and profitable ayahuasca retreat

    Publicerades: 2022-09-14
  17. Microdosing (part 3): The path to FDA approval w/ MindMed and Diamond Therapeutics

    Publicerades: 2022-08-16
  18. Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti

    Publicerades: 2022-08-10
  19. Microdosing (part 1): James Fadiman and the fundamentals of microdosing

    Publicerades: 2022-08-03
  20. How the DEA and FDA will regulate psychedelic medicine

    Publicerades: 2022-06-24

2 / 3

Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more. 

Visit the podcast's native language site